Pfizer Renews Services Pact With Parexel, ICON
Pfizer has renewed its services agreements with two contract research organizations, Parexel International and ICON.
Parexel has signed a services agreement with Pfizer. Under the terms of this agreement, Parexel will continue to provide global clinical research and development services to Pfizer in support of clinical development programs across its portfolio. Terms of the agreement were not disclosed.
Separately, ICON it has signed a three-year agreement with Pfizer. Under the terms of the agreement, Pfizer has the right to extend the term for up to an additional two years. Financial details of the agreement were not disclosed. The new agreement builds on the companies' existing relationship, under which ICON provides global expertise in the planning, execution, management and conduct of clinical trials.
